Trastuzumab deruxtecan in patients with HER2-positive advanced colorectal cancer (DESTINY-CRC02): primary results from a multicentre, randomised, phase 2 trialKanwal Raghav, Takayuki Yoshino, Filippo Pietrantonio et al.|The Lancet Oncology|2024Cited by 124
Immune checkpoint inhibitor-induced severe epidermal necrolysis mediated by macrophage-derived CXCL10 and abated by TNF blockadeChun‐Bing Chen, Wen‐Hung Chung, John Wen-Cheng Chang et al.|Nature Communications|2024Cited by 23
Propyl gallate inhibits TPA-induced inflammation via the nuclear factor-κB pathway in human THP-1 monocytesHung‐Chih Hsu, Ching‐Hsein Chen|Experimental and Therapeutic Medicine|2013Cited by 8